January 2012

Actos Bladder Cancer Lawsuit

Victims continue to file Actos lawsuits against Takeda Pharmaceuticals

Actos (pioglitazone) is a medication used to regulate insulin in patients diagnosed with type II diabetes.

Yaz Birth Control Lawsuit - Consumer Drug Report

Yaz® trials to Proceed if Mediation Fails

The U.S.

Yaz Birth Control Lawsuit - Consumer Drug Report

FDA advisory committee ordered to conduct new Yaz and Yasmin meeting

On December 8, 2011, the FDA advisory panel met to discuss the benefits and risks of birth contraceptives Yaz® and Ya

Actos Bladder Cancer Lawsuit

European Commission advocates Actos as valid treatment

Despite the concerns associated with the linkage between Actos and bladder cancer, the European Commission advocates that Actos is still a

Yaz Birth Control Lawsuit - Consumer Drug Report

Documents reveal three FDA advisory panel members previously worked for Bayer

The FDA Advisory committee, which voted against a Yaz® and Yasmin® recall during December, is being questioned ab

Judge prolongs Yaz case

Bayer, the manufacturer of Yaz and Yasmin®, now faces over 10,000 lawsuits brought by women who allege

Yaz Birth Control Lawsuit - Consumer Drug Report

Increased blood clot risk associated with newer birth controls

A recent study conducted by Danish researchers has concluded that newer birth control medications including

Actos Bladder Cancer Lawsuit

Actos litigation centralized in Louisiana

Actos (pioglitazone) was first introduced in July of 1999 and was designed to aid the body’s sensitivity to insulin in patients that have been diagnosed with type II diabetes.